Euglycemic Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Review of the Literature

Abstract

This paper provides an overview of euglycemic diabetic ketoacidosis (euDKA) associated with the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors. euDKA is a rare but potentially life-threatening complication that can occur in patients taking SGLT2 inhibitors, and its clinical presentation differs from traditional diabetic ketoacidosis. This paper discusses the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of euDKA. Prompt recognition and appropriate treatment are critical to prevent morbidity and mortality. Healthcare providers should be aware of the potential risk of euDKA in patients taking SGLT2 inhibitors and educate them on the signs and symptoms of this serious complication. Further research is needed to better understand the pathophysiology of euDKA and identify strategies for itsprevention and treatment.

Authors and Affiliations

Dafne Sherlyn Moreno Sanchez , Jiany FroylanDe Paz Larios , Jorge Manuel García Salas , Jorge Armando Duarte Salazar , Guadalupe Linares García

Keywords

Related Articles

Gastroschisis: Understanding its Etiopathogenesis

Gastroschisis has been defined as a malformation of the abdominal wall that classically presents as a visceral herniation with the presence of an intact umbilical cord and absence of a membrane covering the abdominal c...

Anal fissure: Surgical management

An anal fissure is a tear or ulceration in the lining of the anal canal below the mucocutaneous junction. Medical treatment cures an anal fissure typical in most patients. Because sphincter preservation is im...

Evolution of Nano composites as Smart Materials: A Systematic Review Study

This review paper is about development and evolution of nanocomposites to smart materials. With the idea of formulating dental materials with long lasting maintenance and functionality, it is important to incorporate cer...

ncidenceofIntestinalObstructionSecondarytoPetersen'sHerniaafterLaparoscopicRoux-en-YGastricBypass

Objective:IdentifytheincidenceofPetersen'sherniaingastricbypasspatientsatourinstitution.Summary:Laparoscopicgastricbypasshasprovedtobethebesttreatmentforobesityandtheresolutionoftheircomplications,however,itpresentslong-...

New ICU Design andPatient Outcome

Hospital length of stay (LOS) is a quality metric health systems use as a proxy of efficient hospital management (1). Many strategies to reduce ICU length of stay (LOS) have been implemented, but few stu...

Download PDF file
  • EP ID EP740057
  • DOI 10.47191/ijmscrs/v3-i4-22
  • Views 65
  • Downloads 0

How To Cite

Dafne Sherlyn Moreno Sanchez, Jiany FroylanDe Paz Larios, Jorge Manuel García Salas, Jorge Armando Duarte Salazar, Guadalupe Linares García (2023). Euglycemic Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Review of the Literature. International Journal Of Medical Science And Clinical Research Studies, 3(4), -. https://europub.co.uk/articles/-A-740057